Equities

Onemednet Corp

ONMD:NAQ

Onemednet Corp

Actions
  • Price (USD)0.6408
  • Today's Change-0.009 / -1.42%
  • Shares traded207.71k
  • 1 Year change-94.26%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.05290.45
Total Receivables, Net0.150.92--
Total Inventory------
Prepaid expenses0.170.100.08
Other current assets, total------
Total current assets0.36300.54
Property, plant & equipment, net0.100.08--
Goodwill, net------
Intangibles, net------
Long term investments----117
Note receivable - long term------
Other long term assets------
Total assets0.4630118
LIABILITIES
Accounts payable------
Accrued expenses0.110.070.13
Notes payable/short-term debt1.598.490
Current portion long-term debt/capital leases0.04----
Other current liabilities, total6.900.410.16
Total current liabilities13120.29
Total long term debt0.474.300
Total debt2.10130
Deferred income tax------
Minority interest------
Other liabilities, total0.025.088.88
Total liabilities13219.17
SHAREHOLDERS EQUITY
Common stock0.0029117
Additional paid-in capital42240
Retained earnings (accumulated deficit)(55)(44)(8.61)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(13)9.27109
Total liabilities & shareholders' equity0.4630118
Total common shares outstanding248.4015
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.